These findings demonstrate that [89Zr]-CD8 immuno-PET is a highly sensitive and specific method for visualizing CD8-positive T-cell dynamics, providing valuable prognostic information and supporting its potential application in guiding personalized immunotherapy strategies for glioblastoma patients. This evidence concerns the gene CD8A and glioblastoma.